Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 18, Issue 9

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Investigational Drugs, Volume 18, Issue 9 (2009)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Investigational Drugs, Volume 18, Issue 9 (2009)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Volume 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Discontinued Drugs Perspective

Article

Discontinued drugs in 2008: endocrine and metabolic

Jerry R Colca

Pages: 1243-1255

Published online: 14 Aug 2009

AbstractforDiscontinued drugs in 2008: endocrine and metabolic | Full Text | References | PDF (339.8 KB)

142 Views
10 CrossRef citations
0Altmetric

Reviews

Article

Is there a palliative benefit of gemcitabine plus fluoropyrimidines in patients with refractory colorectal cancer? A review of the literature

Previously presented: Poster at the 2008 Gastrointestinal Cancer Symposium (Abstract No. 512)

MY Merl, CJ Hoimes, T Pham & M Wasif Saif

Pages: 1257-1264

Published online: 11 Jul 2009

AbstractforIs there a palliative benefit of gemcitabine plus fluoropyrimidines in patients with refractory colorectal cancer? A review of the literature | Full Text | References | PDF (234.8 KB)

181 Views
10 CrossRef citations
0Altmetric

Article

Novel inhibitors of the PI3K family

Amancio Carnero

Pages: 1265-1277

Published online: 10 Jul 2009

AbstractforNovel inhibitors of the PI3K family | Full Text | References | PDF (350.7 KB)

503 Views
29 CrossRef citations
0Altmetric

Article

New generation azole antifungals in clinical investigation

Corrado Girmenia

Pages: 1279-1295

Published online: 14 Aug 2009

AbstractforNew generation azole antifungals in clinical investigation | Full Text | References | PDF (333.6 KB)

694 Views
78 CrossRef citations
0Altmetric

Article

Somatostatin and somatostatin receptors: implications for neoplastic growth and cancer biology

Pavlos Msaouel MD, Evanthia Galanis MD & Michael Koutsilieris MD PhD

Pages: 1297-1316

Published online: 14 Aug 2009

AbstractforSomatostatin and somatostatin receptors: implications for neoplastic growth and cancer biology | Full Text | References | PDF (558.3 KB)

282 Views
24 CrossRef citations
0Altmetric

Article

Platelet P2Y12 receptor inhibition by thienopyridines: status and future

Italo Porto MD PhD, Simona Giubilato, Giovanni Luigi De Maria, Luigi Marzio Biasucci & Filippo Crea

Pages: 1317-1332

Published online: 14 Aug 2009

AbstractforPlatelet P2Y12 receptor inhibition by thienopyridines: status and future | Full Text | References | PDF (410.8 KB)

322 Views
19 CrossRef citations
0Altmetric

Article

Targeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia

Alberto M Martelli MD PhD, Camilla Evangelisti PhD, Francesca Chiarini BSc, Cecilia Grimaldi BSc, Lucia Manzoli MD PhD & James A McCubrey PhD

Pages: 1333-1349

Published online: 14 Aug 2009

AbstractforTargeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia | Full Text | References | PDF (392.5 KB)

679 Views
91 CrossRef citations
0Altmetric

Article

Novel targets in esophageal and gastric cancer: beyond antiangiogenesis

Wooin Lee, Jignesh H Patel & A Craig Lockhart

Pages: 1351-1364

Published online: 30 Jul 2009

AbstractforNovel targets in esophageal and gastric cancer: beyond antiangiogenesis | Full Text | References | PDF (381 KB)

202 Views
18 CrossRef citations
0Altmetric

Drug Evaluations

Article

Rosiglitazone maleate + metformin hydrochloride extend: review of an emerging compound

Alice YY Cheng MD FRCPC & Robert G Josse BSc MBBS FRCP FRCPC FACP FACE

Pages: 1365-1373

Published online: 30 Jul 2009

AbstractforRosiglitazone maleate + metformin hydrochloride extend: review of an emerging compound | Full Text | References | PDF (275 KB)

71 Views
1 CrossRef citations
0Altmetric

Article

Retaspimycin hydrochloride (IPI-504): a novel heat shock protein inhibitor as an anticancer agent

Britt Erika Hanson DO & David H Vesole MD PhD

Pages: 1375-1383

Published online: 30 Jul 2009

AbstractforRetaspimycin hydrochloride (IPI-504): a novel heat shock protein inhibitor as an anticancer agent | Full Text | References | PDF (299.4 KB)

299 Views
39 CrossRef citations
0Altmetric

Article

A fixed dose combination of ibuprofen and famotidine

John W Birk & Matthew Myers

Pages: 1385-1391

Published online: 06 Aug 2009

AbstractforA fixed dose combination of ibuprofen and famotidine | Full Text | References | PDF (228.4 KB)

161 Views
4 CrossRef citations
0Altmetric

Article

Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination

Susanne Perkhofer & Cornelia Lass-Flörl

Pages: 1393-1404

Published online: 05 Aug 2009

AbstractforAnidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination | Full Text | References | PDF (342.3 KB)

251 Views
9 CrossRef citations
0Altmetric

Article

Taspoglutide: a long acting human glucagon-like polypeptide-1 analogue

Kjetil Retterstøl

Pages: 1405-1411

Published online: 14 Aug 2009

AbstractforTaspoglutide: a long acting human glucagon-like polypeptide-1 analogue | Full Text | References | PDF (247.5 KB)

256 Views
19 CrossRef citations
0Altmetric

Article

Corticorelin acetate injections for the treatment of peritumoral brain edema

Jennifer A Moliterno MD, Euphael Henry MD & Susan C Pannullo MD

Pages: 1413-1419

Published online: 14 Aug 2009

AbstractforCorticorelin acetate injections for the treatment of peritumoral brain edema | Full Text | References | PDF (220.6 KB)

117 Views
8 CrossRef citations
0Altmetric

Key Paper Evaluation

Article

Golimumab for severe asthma

Evaluation: Wenzel SE, Barnes PJ, Bleecker ER et al. A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma. Am J Respir Crit Care Med 2009;179(7):549-58

Sabina A Antoniu MD PhD

Pages: 1421-1423

Published online: 14 Aug 2009

AbstractforGolimumab for severe asthma | Full Text | References | PDF (178.1 KB)

126 Views
8 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Inflammation and Huntington’s disease- a neglected therapeutic target?

Sophie E. Field et al.

Review Article | Published online: 17 May 2024

Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status

Fernanda Karoline Vieira da Silva Torchelsen et al.

Review Article | Published online: 14 May 2024

Emerging therapies for overactive bladder: preclinical, phase I and phase II studies

Samantha Gibson et al.

Review Article | Published online: 9 May 2024

Frontotemporal dementia: from genetics to therapeutic approaches

Francesca R. Buccellato et al.

Review Article | Published online: 9 May 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.18, Iss.9, 2009)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?